[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2154636T3 - Composiciones farmaceuticas conteniendo imidazoles 4-sustituidos para su administracion por via transdermica. - Google Patents

Composiciones farmaceuticas conteniendo imidazoles 4-sustituidos para su administracion por via transdermica.

Info

Publication number
ES2154636T3
ES2154636T3 ES92910941T ES92910941T ES2154636T3 ES 2154636 T3 ES2154636 T3 ES 2154636T3 ES 92910941 T ES92910941 T ES 92910941T ES 92910941 T ES92910941 T ES 92910941T ES 2154636 T3 ES2154636 T3 ES 2154636T3
Authority
ES
Spain
Prior art keywords
pct
transdermal
administration
imidazols
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910941T
Other languages
English (en)
Inventor
Harry Jalonen
Risto Lammintausta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Application granted granted Critical
Publication of ES2154636T3 publication Critical patent/ES2154636T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ESTA INVENCION ES RELATIVA A UNA PREPARACION TRANSDERMAL QUE COMPRENDE UN COMPUESTO TERAPEUTICAMENTE ACTIVO DE FORMULA (I) O (II) DONDE R1, R2 Y R3 LOS CUALES PUEDEN SER EL MISMO O DIFERENTE SON H, CH3, C2H5 O CL; X ES CH=CH O (CH2)N, DONDE N ES DE 1 A 3 O X ES -C(OR5)H-, DONDE R5 ES METILO O ETILO; Y R4 ES HIDROGENO O UN ALQUILO LINEAL DE 1 A 4 ATOMOS DE CARBONO. LA ADMINISTRACION TRANSDERMAL DEL COMPUESTO PUEDE SER ACOMPAÑADA POR PREPARACIONES EN LA FORMA DE UNGUENTOS, EMULSIONES, LOCIONES, SOLUCIONES, CREMAS, GELES O PARCHES TRANSDERMICOS.
ES92910941T 1991-05-31 1992-05-27 Composiciones farmaceuticas conteniendo imidazoles 4-sustituidos para su administracion por via transdermica. Expired - Lifetime ES2154636T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9111773A GB2256135B (en) 1991-05-31 1991-05-31 Transdermal administration of 4-substituted imidazoles

Publications (1)

Publication Number Publication Date
ES2154636T3 true ES2154636T3 (es) 2001-04-16

Family

ID=10695905

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910941T Expired - Lifetime ES2154636T3 (es) 1991-05-31 1992-05-27 Composiciones farmaceuticas conteniendo imidazoles 4-sustituidos para su administracion por via transdermica.

Country Status (18)

Country Link
US (1) US5464628A (es)
EP (1) EP0586467B1 (es)
JP (1) JP3269822B2 (es)
AT (1) ATE199317T1 (es)
AU (1) AU1780892A (es)
CA (1) CA2110162C (es)
DE (1) DE69231709T2 (es)
DK (1) DK0586467T3 (es)
EE (1) EE02994B1 (es)
ES (1) ES2154636T3 (es)
FI (1) FI935350A0 (es)
GB (1) GB2256135B (es)
GR (1) GR3035499T3 (es)
IE (1) IE66188B1 (es)
LT (1) LT3005B (es)
LV (1) LV10042B (es)
NO (1) NO307365B1 (es)
WO (1) WO1992021334A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
CA2588732C (en) * 2004-12-15 2012-09-11 Teikoku Seiyaku Co., Ltd. External patches containing etofenamate
AU2007209380B2 (en) 2006-01-27 2011-12-08 F. Hoffmann-La Roche Ag Use of 4-imidazole derivatives for CNS disorders
ES2341138T3 (es) * 2006-08-08 2010-06-15 Intervet International Bv Composicion con actividad antiparasitaria mejorada.
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US20210323929A1 (en) * 2018-07-18 2021-10-21 Clexio Biosciences Ltd. Purified Detomidine, Process of Preparing and Methods of Use
EP3962478A1 (en) 2019-05-01 2022-03-09 Clexio Biosciences Ltd. Methods of treating pruritus
CN112220767B (zh) * 2020-09-25 2022-10-25 安徽省公众检验研究院有限公司 一种盐酸阿替美唑缓释片的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
GB2167408B (en) 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
US4672344A (en) 1985-04-19 1987-06-09 Siemens Aktiengesellschaft Polarized electromagnetic relay
FI864570A0 (fi) 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Also Published As

Publication number Publication date
US5464628A (en) 1995-11-07
LTIP111A (lt) 1994-03-25
FI935350A (fi) 1993-11-30
JPH06507618A (ja) 1994-09-01
JP3269822B2 (ja) 2002-04-02
EP0586467B1 (en) 2001-02-28
EE02994B1 (et) 1997-06-16
LV10042B (en) 1995-02-20
GB9111773D0 (en) 1991-07-24
LT3005B (lt) 1994-08-25
EP0586467A1 (en) 1994-03-16
FI935350A0 (fi) 1993-11-30
CA2110162C (en) 2002-11-12
NO307365B1 (no) 2000-03-27
DE69231709T2 (de) 2001-10-04
ATE199317T1 (de) 2001-03-15
GB2256135B (en) 1995-01-18
NO934261L (no) 1993-11-25
DE69231709D1 (de) 2001-04-05
WO1992021334A1 (en) 1992-12-10
IE66188B1 (en) 1995-12-13
GB2256135A (en) 1992-12-02
GR3035499T3 (en) 2001-06-29
IE921938A1 (en) 1992-12-02
DK0586467T3 (da) 2001-03-26
CA2110162A1 (en) 1992-12-10
AU1780892A (en) 1993-01-08
LV10042A (lv) 1994-05-10
NO934261D0 (no) 1993-11-25

Similar Documents

Publication Publication Date Title
ES2154636T3 (es) Composiciones farmaceuticas conteniendo imidazoles 4-sustituidos para su administracion por via transdermica.
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
BE904226A (fr) Derives 4-substitues d'androst-4-ene-3,17-dione utiles notamment comme inhibiteurs d'aromatase et leur fabrication.
GB1536515A (en) Compositions containing silicon derivatives
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
KR890016017A (ko) 치환된 1-(1h-이미다졸-4-일)알킬-벤즈아미드
ES8609225A1 (es) Un procedimiento para preparar un derivado de semicarbazida
ES8305003A1 (es) "procedimiento para la preparacion de derivados de androstano".
DK601683D0 (da) Dialkylaminoalkoxybenzylalkoholderivater
NO173057C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzanilidderivater
ME00300B (me) NOVI DERIVATI OKT AHIDR0-6, 10-DIOKS0-6N-PIRIDAZINO/l,2-a/ /l,2/DIAZEPIN-1-KARBOKSILNE KISELINE, NJIHOV POSTUPAK DOBIJANJA I NJIHOVA PRIMENA ZA DOBIJANJE TERAPEUTSKI AKTIVNIH JEDINJENJA
DE69303605D1 (de) Unverbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
ES8300675A1 (es) Procedimiento de preparacion de derivados de etanolamina.
DK601983D0 (da) Aminoethoxybenzylalkoholderivater
KR910021373A (ko) 1-페녹시카보닐-2-피롤리디논 유도체 및 향정신성 약제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 586467

Country of ref document: ES